BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21822956)

  • 1. Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?
    Schindera C; Wingeier K; Goeggel Simonetti B; Diepold M; Nauer CB; Fleischhauer J; Steinlin M
    Childs Nerv Syst; 2011 Dec; 27(12):2107-11. PubMed ID: 21822956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
    J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1.
    Morris SM; Monroe CL; Gutmann DH
    J Child Neurol; 2016 Dec; 31(14):1540-1545. PubMed ID: 27581847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
    Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
    Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
    J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
    J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myopia associated with optic nerve gliomas in neurofibromatosis type 1.
    de Alba Campomanes AG; Avery RA; Prasad S; Liu GT
    J AAPOS; 2012 Feb; 16(1):89-91. PubMed ID: 22370674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ
    Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Strabismus Among Children With Neurofibromatosis Type 1 Disease With and Without Optic Pathway Glioma.
    Dotan G; Qureshi HM; Toledano-Alhadef H; Azem N; Yahalom C
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):19-22. PubMed ID: 30371910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic pathway glioma with intraocular extension in a child with neurofibromatosis type-1.
    Palma-Carvajal F; González-Valdivia H; Figueroa-Vercellino JP; Saavedra-Gutiérrez C; Rovira-Zurriaga C; Prat-Bartomeu J
    J Fr Ophtalmol; 2020 May; 43(5):e179-e181. PubMed ID: 32241588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
    Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
    Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.